The Importance of Medicaid Data To Improve Diversity in Clinical Trials
Paralleling many conversations across the current socio-political landscape, life sciences have been striving to fix the lack of diversity in clinical trials. This has taken a few different angles ranging from access to representative results. While these conversations have been ongoing, two recent updates prompted more urgent action: Medicaid became responsible for the costs of…